Jelena Kravarusic is an Endocrinology/Metabolic physician affiliated with Northwestern University. OpenAlex indexes 20 publications with 1,082 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
675 N Saint Clair St Ste 701
Chicago, IL 606115975
Telephone
312-695-7970Provider last certified this registry record 6 May 2026.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20252 payments
- Amgen Inc.Program year20241 payment
- Novo Nordisk IncProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
73.6%RANK Ligand Inhibitor72.9%Denosumab100%Part B, office-administered≥21 patientsBisphosphonates0.7%Risedronate Sodium100%Part D<11 patientsMetabolism & gastrointestinal
13.4%GLP-1 receptor agonist4.1%Ozempic63%Trulicity21%Mounjaro17%Part D<11 patientsInsulin Analog3.9%Lantus Solostar26%Fiasp Flextouch18%Humalog Kwikpen U-10015%Novolog Flexpen12%Basaglar Kwikpen U-10010%Fiasp10%Humalog10%Part D<11 patients+ 4 more classes in this area
Hormonal (systemic)
11.6%l-Thyroxine8.6%Levothyroxine Sodium71%Synthroid20%Levoxyl9%Part D<11 patientsParathyroid Hormone Analog1.4%Teriparatide61%Forteo39%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
New England Journal of Medicine
2025 - A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
Obstetrical & Gynecological Survey
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”